Exencial Wealth Advisors LLC Buys New Shares in Synopsys, Inc. $SNPS

Exencial Wealth Advisors LLC purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 23,412 shares of the semiconductor company’s stock, valued at approximately $11,551,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Alpine Bank Wealth Management raised its holdings in shares of Synopsys by 89.3% in the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock valued at $26,000 after purchasing an additional 25 shares during the period. TFC Financial Management Inc. lifted its position in shares of Synopsys by 1,250.0% in the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock valued at $27,000 after buying an additional 50 shares during the last quarter. Independence Bank of Kentucky boosted its stake in shares of Synopsys by 120.0% during the 2nd quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after acquiring an additional 30 shares during the period. SOA Wealth Advisors LLC. bought a new stake in Synopsys in the 3rd quarter valued at $28,000. Finally, McIlrath & Eck LLC acquired a new stake in Synopsys during the 3rd quarter valued at $29,000. Institutional investors own 85.47% of the company’s stock.

Wall Street Analyst Weigh In

SNPS has been the topic of a number of research reports. JPMorgan Chase & Co. upped their price target on shares of Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a research note on Thursday, December 11th. Weiss Ratings reissued a “hold (c)” rating on shares of Synopsys in a research report on Wednesday, October 8th. Wall Street Zen upgraded shares of Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Zacks Research raised shares of Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. Finally, BNP Paribas initiated coverage on shares of Synopsys in a research report on Thursday, October 2nd. They issued an “underperform” rating and a $425.00 price target for the company. Nine research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Synopsys presently has a consensus rating of “Hold” and a consensus price target of $553.57.

Check Out Our Latest Research Report on SNPS

Insiders Place Their Bets

In other news, insider Janet Lee sold 250 shares of the business’s stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the transaction, the insider owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. The trade was a 2.05% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the sale, the chief financial officer owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 4,157 shares of company stock valued at $1,945,036 in the last three months. 0.62% of the stock is owned by insiders.

Synopsys Price Performance

Shares of NASDAQ:SNPS opened at $511.80 on Wednesday. The firm has a 50 day moving average of $448.73 and a 200-day moving average of $505.02. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $97.92 billion, a PE ratio of 64.06, a PEG ratio of 4.44 and a beta of 1.12.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The business had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.25 billion. During the same period last year, the firm posted $3.40 earnings per share. The firm’s quarterly revenue was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, equities research analysts predict that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Stories

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.